Anthropometry (8)
- bmi - Body mass index (phv00265289.v3.p1)
- BMI - Body Mass Index (phv00565302.v1.p1)
- height - Height (phv00265287.v2.p1)
- hip - Hip circumference (phv00265290.v2.p1)
- hip - Hip circumference (phv00565304.v1.p1)
- waist - Waist circumference (phv00265291.v2.p1)
- waist - Waist circumference (phv00565303.v1.p1)
- weight - Weight (phv00265288.v2.p1)
Biomarkers (25)
- B_GHbA1C - Whole Blood GHbA1c (phv00565307.v1.p1)
- chol - Total cholesterol (phv00265283.v2.p1)
- cpep_fast - Serum C-peptide (phv00265276.v2.p1)
- dbp - Diastolic blood pressure (phv00435312.v2.p1)
- DBP - Diastolic blood pressure (phv00565319.v1.p1)
- glu_2h - OGTT 120 min plasma glucose (phv00265277.v2.p1)
- glu_fast - OGTT fasting plasma glucose (phv00265274.v2.p1)
- hba1c - Blood GHbA1C (phv00265279.v3.p1)
- hdl - HDL cholesterol (phv00265285.v2.p1)
- ins_2h - OGTT 120 min plasma insulin (phv00435310.v1.p1)
- ins_fast - OGTT fasting plasma insulin (phv00435309.v1.p1)
- ldl - LDL cholesterol (phv00265284.v2.p1)
- P_gl0 - Fasting plasma glucose from OGTT (Oral Glucose Tolerance Test) (phv00565308.v1.p1)
- P_gl120 - 120 min plasma glucose from OGTT (Oral Glucose Tolerance Test) (phv00565309.v1.p1)
- P_ins0 - Fasting plasma insulin from OGTT (Oral Glucose Tolerance Test) (phv00565310.v1.p1)
- S_alat - Alanine aminotransferase (phv00565316.v1.p1)
- S_hdlc - HDL cholesterol (phv00565315.v1.p1)
- s_krea - Creatinine (phv00265281.v2.p1)
- S_krea - Creatinine (phv00565317.v1.p1)
- S_ldlc - LDL cholesterol (phv00565313.v1.p1)
- S_totalc - Total cholesterol (phv00565314.v1.p1)
- S_tottg - Total triglycerides (phv00565312.v1.p1)
- sbp - Systolic blood pressure (phv00435311.v2.p1)
- SBP - Systolic blood pressure (phv00565318.v1.p1)
- tg - Total triglycerides (phv00265286.v2.p1)
Demographics (6)
- Age - Age at examination date (phv00565301.v1.p1)
- aoo - Age of onset of diabetes (phv00265273.v2.p1)
- sex - Sex (phv00265270.v2.p1)
- SEX - Sex (phv00543159.v1.p1)
- SEX - Biological sex (phv00480719.v2.p1)
- studyage - Age at METSIM baseline visit (phv00435306.v2.p1)
Medications (3)
- bpmeds - Use of blood pressure medication (phv00265295.v2.p1)
- diabmeds - Use of diabetes medication (phv00265294.v2.p1)
- lipidmeds - Use of lipid medication (phv00265296.v2.p1)
Other (28)
- Biopsy_Number - Biopsy number (phv00565298.v1.p1)
- cohort - T2D-GENES cohort name (phv00265298.v2.p1)
- CONSENT - Consent group (phv00251851.v3.p1)
- consortium - Consortium name (phv00265297.v2.p1)
- Difference_Biopsy_and_Visit - Time difference between examination and biopsy (phv00565300.v1.p1)
- dmtype - Type of diabetes (phv00435307.v1.p1)
- FAMILY_ID - Family ID (phv00480715.v2.p1)
- FATHER - Father's Subject ID (phv00480717.v2.p1)
- fatmass - Fat mass from Bioimpedance (phv00565306.v1.p1)
- gltol6_1 - Glucose tolerance according to WHO 1997 (phv00435308.v1.p1)
- matsuda - Matsuda index (ISIcomp) (phv00565311.v1.p1)
- MOTHER - Mother's Subject ID (phv00480718.v2.p1)
- p_adipon - Plasma adiponectin (phv00265282.v2.p1)
- s_gadab - Serum GAD antibodies (phv00265280.v2.p1)
- SAMPLE_ID - Sample ID (phv00251859.v4.p1)
- SOURCE_SUBJECT_ID - Source subject ID (phv00409060.v2.p1)
- SOURCE_SUBJECT_ID2 - Source subject ID (phv00543161.v1.p1)
- STUDY - Study accession (phv00251860.v4.p1)
- SUBJECT_ID - Subject ID (phv00265269.v2.p1)
- SUBJECT_ID - Subject ID (phv00565297.v1.p1)
- SUBJECT_ID - Deidentified subject ID (phv00251850.v3.p1)
- SUBJECT_ID - Subject ID (phv00480716.v2.p1)
- SUBJECT_ID - Subject ID (phv00251858.v4.p1)
- SUBJECT_SOURCE - Subject source (phv00409059.v2.p1)
- SUBJECT_SOURCE2 - Subject source (phv00543160.v1.p1)
- Time_between_Biopsies - Time since previous biopsy (phv00565299.v1.p1)
- TWIN_ID - Twin ID for monozygotic twins and multiples. An MZ_TWIN_ID is not provided for dizygotic twins or multiples. (phv00480720.v2.p1)
- WHR - Waist/hip ratio (phv00565305.v1.p1)